Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
This study has been completed.
Study NCT00526812   Information provided by Reata Pharmaceuticals, Inc.
First Received: September 7, 2007   Last Updated: December 19, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glioma
Additional conditions recognized in this trial
Oligodendroglioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Interventions listed in this trial
RTA 744
RTA 744 injection
Sponsors listed in this trial
Reata Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services